Early clinical outcomes: Dr. Brian Potter discusses the experience of a patient who participated in an early feasibility study of the Alleviant investigational device for chronic heart failure.
The investigational Alleviant technology is currently being evaluated in the ALLAY-HF and ALLAY-HFrEF clinical trials. To learn more, visit: alleviantmedical.com
CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only.
#HeartFailure#InterventionalCardiology#StructuralHeart#InterventionalHeartFailure#ClinicalResearch#HFpEF#HFrEF#Cardiology#HeartFailureAwareness#Epeeps
Early clinical outcomes: Dr. Rob Gooley discusses the experience of a patient who participated in an early feasibility study of the Alleviant investigational device for chronic heart failure.
The Alleviant device is currently being evaluated in the ALLAY-HF and ALLAY-HFrEF clinical trials. To learn more, visit: alleviantmedical.com
CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only.
#HeartFailure#InterventionalCardiology#StructuralHeart#InterventionalHeartFailure#ClinicalResearch#HFpEF#HFrEF#Cardiology#HeartFailureAwareness#Epeeps
The Alleviant System is an investigational device currently being studied in patients suffering from heart failure who are symptomatic despite currently available therapies. The device is designed to create an interatrial shunt through a minimally invasive procedure without requiring open heart surgery.
Watch to learn more about the minimally invasive technology being evaluated in the ALLAY-HF and ALLAY-HFrEF clinical trials:
CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only.
#HeartFailure#InterventionalCardiology#StructuralHeart#InterventionalHeartFailure#ClinicalResearch#HFpEF#HFrEF#Cardiology#HeartFailureAwareness#Epeeps
Many people with chronic heart failure experience pressure buildup inside the heart, which contributes to symptoms such as shortness of breath and fatigue.
Interatrial shunting is an investigational device-based approach designed to relieve the excess pressure. The goal: create a small pathway or "pressure relief valve" for blood to flow from a higher-pressure chamber to a lower-pressure chamber within the heart.
Researchers are currently evaluating this approach in the ALLAY-HF and ALLAY-HFrEF clinical trials.
Watch Dr. James Udelson explain the science behind this investigational procedure.
CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only.
#HeartFailure#InterventionalCardiology#StructuralHeart#InterventionalHeartFailure#ClinicalResearch#HFpEF#HFrEF#Cardiology#HeartFailureAwareness